ALLMedicine™ Acute Disseminated Encephalomyelitis Center
Research & Reviews 458 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030273
Journal of Clinical Neuroscience : Official Journal of Th... Nabizadeh F, Noori M et. al.
Mar 25th, 2023 - Although global vaccination against COVID-19 infection has its excellence, potential side effects are yet of concern. Several lines of evidence have proposed ADEM occurrence after SARS-CoV-2 infection. Moreover, a large number of case reports and ...
https://clinicaltrials.gov/ct2/show/NCT05017142
Mar 14th, 2023 - Background: Pediatric onset MS and other inflammatory brain diseases (IBrainDs) are severe diseases affecting children and adolescents in a period of essential brain development. This possibly leads to a variety of focal neurological deficits as w...
https://doi.org/10.1177/13524585231156736
Multiple Sclerosis (Houndmills, Basingstoke, England); Nakamura M, Ogawa R et. al.
Mar 12th, 2023 - To our knowledge, no nationwide epidemiological study of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has been conducted. We examined the epidemiology and clinical features of MOGAD in Japan. We distributed questionnaire...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983520
Journal of Neurovirology; Marín-Medina DS, Castilla-Gómez L et. al.
Mar 4th, 2023 - A new outbreak of monkeypox has been reported worldwide with CNS complications like encephalitis or myelitis being extremely rare. We present a case of a 30-year-old man with PCR-confirmed diagnosis of monkeypox who developed rapid neurological de...
https://www.mdedge.com/neurology/article/261536/multiple-sclerosis/mogad-immunotherapy-predicts-fewer-relapses
Jim Kling
Mar 1st, 2023 - SAN DIEGO – A new retrospective analysis of patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD) indicates that treatment with immunotherapy is associated with a lower risk of relapse. The authors note that many MOGAD patient.
Clinicaltrials.gov 10 results
https://clinicaltrials.gov/ct2/show/NCT05017142
Mar 14th, 2023 - Background: Pediatric onset MS and other inflammatory brain diseases (IBrainDs) are severe diseases affecting children and adolescents in a period of essential brain development. This possibly leads to a variety of focal neurological deficits as w...
https://clinicaltrials.gov/ct2/show/NCT02906631
Feb 23rd, 2023 - Acute encephalitis (AE) is a serious condition associated with significant morbidity and mortality. Patients require ICU admission in 60 % of cases, mainly because of neurological symptoms (coma, seizures) or acute respiratory failure. The etiolog...
https://clinicaltrials.gov/ct2/show/NCT05630313
Nov 29th, 2022 - Participants higher than 5 years old with no maximum age limit and both sexes, who had a serious adverse event after vaccination against Covid-19, such as myocarditis, pericarditis, Guillain-Barré syndrome, vaccine-induced immune thrombotic thromb...
https://clinicaltrials.gov/ct2/show/NCT05576714
Oct 14th, 2022 - Background for COVID-19 associated encephalopathy/encephalitis in children The COVID-19 primarily cause the respiratory diseases, such as croup, bronchiolitis, or pneumonia, but it also can affect the nervous system. According to the data of 1,695...
https://clinicaltrials.gov/ct2/show/NCT00445367
Jul 20th, 2021 - To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADE...
News 45 results
https://www.mdedge.com/neurology/article/261536/multiple-sclerosis/mogad-immunotherapy-predicts-fewer-relapses
Jim Kling
Mar 1st, 2023 - SAN DIEGO – A new retrospective analysis of patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD) indicates that treatment with immunotherapy is associated with a lower risk of relapse. The authors note that many MOGAD patient.
https://www.medpagetoday.com/infectiousdisease/vaccines/103344
Mar 1st, 2023 - A panel of FDA’s outside advisors recommended the agency approve GSK’s respiratory syncytial virus (RSV) vaccine for older adults, a day after backing Pfizer’s RSV vaccine candidate for that same population. By votes of 12-0 on efficacy and 10-2 o...
https://www.medpagetoday.com/neurology/generalneurology/100700
Sep 14th, 2022 - Brain inflammation and spinal cord lesions associated with monkeypox were identified in two men in the U.S., according to a report published by the CDC. In two previously healthy young gay men with confirmed systemic monkeypox virus infections, en...
https://www.medpagetoday.com/neurology/generalneurology/100324
Aug 19th, 2022 - As human monkeypox cases rise, neurologists should be prepared to recognize, diagnose, and treat potentially neuroinvasive disease or other neurologic symptoms, experts said. Monkeypox virus has the potential to be neuroinvasive based on animal mo...
https://www.medpagetoday.com/neurology/generalneurology/97590
Mar 9th, 2022 - Neurologic adverse events after COVID-19 vaccination were rare, an analysis of Vaccine Adverse Event Reporting System (VAERS) data showed. Of nearly 307 million COVID vaccine doses administered in the U.S. in the first half of 2021, 314,610 (0.1%)...